Forbes Journal of Medicine, as a double-blind peer-reviewed journal, includes experimental, basic, original clinical studies in the field of Medicine and Health Sciences and is published three times a year (in April, August and December); publishes reviews, case reports, and letter articles to the editor. The referees that editors will consider as the main factor in the selection of the manuscript are selected from external independent persons who are experts in their fields. We aim to qualify the journal as a publication where academicians of Medicine and Health Sciences will have the opportunity to share their scientific studies by publishing and benefit as a reference.
Studies that emphasize these aims provide the basis for publication, including original articles, reviews, case reports, letters to the editor, and annual meetings' abstracts. All articles must be submitted to Forbes Journal of Medicine exclusively with the understanding that they have not been published previously in print or electronic format and not under consideration by any other journal or electronic medium for publication.
All submitted manuscripts are first evaluated by the editorial board in terms of compliance with the journal's publishing policies. Appropriate articles are sent to double blind peer review. After the articles are received, they are evaluated and the first decision is forwarded to the author within two months.
The editorial and publication process of the Forbes Journal of Medicine are shaped in accordance with the guidelines of the International Committee of Medical Journal Editors (ICMJE), World Association of Medical Editors (WAME), Council of Science Editors (CSE), Committee on Publication Ethics (COPE), European Association of Science Editors (EASE), and National Information Standards Organization (NISO). The journal is in conformity with the Principles of Transparency and Best Practice in Scholarly Publishing.
Forbes Journal of Medicine is indexed in Ulakbim TR Dizin, Turkey Citation Index, EBSCO, Türk Medline, J-Gate, Gale and DOAJ.
Journal Title (English): Forbes Journal of Medicine
Journal Title (Turkish): Forbes Tıp Dergisi
Official Abbreviation: Forbes J Med
This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge.
Author (s) and copyright owner (s) grant access to all users for the articles published in the Forbes Journal of Medicine as free of charge. Articles may be used provided that they are cited.
Open Access Policy is based on rules of Budapest Open Access Initiative (BOAI). By “open access” to [peer-reviewed research literature], we mean its free availability on the public internet, permitting any users to read, download, copy, distribute, print, search, or link to the full texts of these articles, crawl them for indexing, pass them as data to software, or use them for any other lawful purpose, without financial, legal, or technical barriers other than those inseparable from gaining access to the internet itself. The only constraint on reproduction and distribution, and the only role for copyright in this domain, should be to give authors control over the integrity of their work and the right to be properly acknowledged and cited.
Forbes Journal of Medicine does not demand any subscription fee, publication fee or similar payment for access to electronic resources.
As of 2023, Forbes Journal of Medicine accepts the "Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0)” for all published articles.
This licence permits third parties to copy, distribute, or reuse the content for non-commercial purposes by giving the appropriate credit to the author and original work. Authors agree to transfer commercial rights to İzmir Buca Seyfi Demirsoy Training and Research Hospital, if the article is accepted for publication.
Open access is an approach that supports interdisciplinary development and encourages collaboration between different disciplines. Therefore, Forbes Journal of Medicine contributes to the scientific publishing literature by providing more access to its articles and a more transparent review process.
Potential advertisers should contact the Editorial Office. Advertisement images are published only upon the Editor-in-Chief’s approval.Material Disclaimer
Statements or opinions stated in articles published in the journal do not reflect the views of the editors, editorial board and/or publisher; The editors, editorial board and publisher do not accept any responsibility or liability for such materials. All opinions published in the journal belong to the authors.Contact
Galenos Publishing House
Address: Molla Gürani Mah. Kaçamak Sok. 21/1 Fındıkzade, Fatih, Istanbul/Turkey
Telephone: +90 212 621 99 25
Fax: +90 212 621 99 27
Web page: http://www.galenos.com.tr
E-mail: [email protected]